The AV400 operates by using infrared light to detect veins be-
neath the skin, then projecting the position of the veins on the
skin surface directly above the veins. Quali ed medical per-
sonnel can observe the vasculature as displayed to assist them
in nding a vein of the right size and position for venipuncture
and other medical procedures requiring the location of super-
cial veins. No training is required to operate the AV400.
The AV400 only shows super cial vasculature. The maximum
depth that veins are displayed varies by patient. In addition,
some patients' veins or a portion of their veins might not be
displayed well or at all. Causes for less than optimal or lack of
vein display include, but are not limited to, vein depth, skin
conditions (e.g., eczema, tattoos), hair, scarring or other high-
ly contoured skin surface, and adipose (fatty) tissue.
ACU0004739D.indd 7
70.8219
70.8219
70.8219
keith@typefl ownyc.com • 917.370.8219
keith@typefl ownyc.com • 917.370.8219
ft page
ft page
ft page
ACU0004962_ENGLISH.indd • May 15, 2017 3:02 PM • right page
ACU0004962_ENGLISH.indd • May 15, 2017 3:02 PM • right page
ACU0004739D • April 5, 2017 5:17 PM • right page
Production 1Pc after translations
Basic Use and Operation
Basic Use and Operation
Product Description
When held directly overhead, the AV400 accurately locates
the center of a vein. Increasing the displacement from direct-
ly overhead results in an o set in the displayed vein position.
Width of displayed vein may di er from the actual width de-
pending on patient to patient di erences and vein width. The
center line of the vein is accurate when the device is being
used correctly and should always be used as the target when
performing venipuncture or other medical procedures.
The AV400 requires no routine or preventative maintenance.
The AV400 is portable internally powered by battery and ap-
proved for continuous operation. The AV400 is considered a
Type B applied part and is not protected by ingress of water.
The technology in the AV400 is covered by the following pat-
ents: US 8,073,531; US 7,904,138; US 8,150,500; US 7,983,738;
US 8,244,333; US 8,255,040; US 8,295,904; US 8,328,368; US
8,380,291; US 8,391,960; US 8,478,386; US 8,463,364; US
8,489,178; EP 1981395B1; Mexico 0357588. Other US and in-
ternational patents pending. Visit www.accuvein.com for the
most current information.
9
7
5/15/17 3:02 PM